Concepedia

Michael J. Abbott

MJ

Statistics

Publications

6

Citations

221

H-Index

6

Active since

1984

Affiliations

Drugs for Neglected Diseases Initiative(Current)

Murdoch University

Monash University

Michael J. Abbott is an author at Drugs for Neglected Diseases Initiative specializing in drug discovery, pharmacology, and medicinal chemistry.

ORCID

Publications per year

1984–2023

6

Publications

6

Analogues of Fenarimol Are Potent Inhibitors of Trypanosoma cruzi and Are Efficacious in a Murine Model of Chagas Disease

Martine Keenan, Michael J. Abbott, Paul W. Alexander et al. · Journal of Medicinal Chemistry · 2012 · 68 citations · Full text

, , +17

Two Analogues of Fenarimol Show Curative Activity in an Experimental Model of Chagas Disease

Martine Keenan, Jason H. Chaplin, Paul W. Alexander et al. · Journal of Medicinal Chemistry · 2013 · 48 citations · Full text

, , +15

Effects of Dietary Energy and Protein Restriction on Nutritional Indices of Female White-Tailed Deer

Robert D. Brown, Eric C. Hellgren, Michael J. Abbott et al. · Journal of Wildlife Management · 1995 · 40 citations

, , +15

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc <sub>1</sub>

Stéphanie Braillard, Martine Keenan, Jacob Heppell et al. · Science Translational Medicine · 2023 · 28 citations · Full text

, , +13

Selection and Optimization of Hits from a High-Throughput Phenotypic Screen Against <i>Trypanosoma Cruzi</i>

Martine Keenan, Paul W. Alexander, Jason H. Chaplin et al. · Future Medicinal Chemistry · 2013 · 22 citations

, , +15

1–5 of 6